Klf15-flox Mouse
Common Name
Klf15-flox
제품 ID
S-CKO-12989
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-66277-Klf15-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Klf15-flox Mouse (카탈로그 번호 S-CKO-12989)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Klf15-flox
품종 계통계통 ID
CKOCMP-66277-Klf15-B6J-VA
유전자명
제품 ID
S-CKO-12989
유전자 별칭
CKLF, KKLF, hlb444, 1810013I09Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 6
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000032174
NCBI 전사체 ID
NM_023184
타겟 영역
Exon 2
유효 영역 크기
~2.0 kb
유전자 연구 개요
Klf15, also known as Krüppel-like factor 15, is a transcription factor with diverse biological functions. It is involved in multiple pathways, such as those related to metabolism, inflammation, and cell-phenotype regulation, playing an overall crucial role in maintaining normal physiological functions and in disease-related processes. Genetic models, like gene knockout (KO) and conditional knockout (CKO) mouse models, are valuable tools for studying Klf15's functions.
In immobility-induced muscle atrophy, mice with skeletal muscle KLF15 deficiency are protected from atrophy, suggesting Klf15 is part of the Piezo1/KLF15/IL-6 axis mediating this atrophy [1]. In cardiac ischemic injury, WWP1 targets KLF15 for polyubiquitination and degradation, exacerbating cardiomyocyte inflammation; inhibition of WWP1 mitigates this [2]. In pancreatic cancer, KLF15 suppresses cancer stem cell stemness by promoting Nanog degradation [3]. In hypertensive renal injury, SIRT7 mitigates renal ferroptosis, fibrosis, and injury by facilitating the KLF15/Nrf2 signaling [4]. In the heart, KLF15 is an inhibitor of pathological cardiac hypertrophy and fibrosis [5]. In liver, KLF15-Cyp3a11 axis regulates rifampicin-induced liver injury; KLF15 knockout attenuates hepatotoxicity of rifampicin [6]. In thoracic aortic dissection, Klf15KO mice are more susceptible to TAD, and KLF15 maintains VSMC contractile phenotype by interacting with MRTFB [7]. In cardiomyocytes, KLF15 deficiency leads to increased oxidative stress due to reduced NAMPT and NAD + levels [8]. In triple-negative breast cancer, exogenous KLF15 suppresses cell growth and metastasis by downregulating CCL2 and CCL7 [9].
In conclusion, Klf15 is involved in a wide range of biological processes including muscle atrophy, cardiac function, cancer stemness, renal injury, and more. The use of Klf15 KO/CKO mouse models has significantly contributed to understanding its role in diseases such as muscle atrophy, cardiac ischemic injury, pancreatic cancer, hypertensive renal injury, and others, providing potential therapeutic targets for these conditions.
References:
1. Hirata, Yu, Nomura, Kazuhiro, Kato, Daisuke, Wake, Hiroaki, Ogawa, Wataru. 2022. A Piezo1/KLF15/IL-6 axis mediates immobilization-induced muscle atrophy. In The Journal of clinical investigation, 132, 1-13. doi:10.1172/JCI154611. https://pubmed.ncbi.nlm.nih.gov/35290243/
2. Lu, Xia, Yang, Boshen, Qi, Ruiqiang, Wang, Yan, Song, Juan. 2023. Targeting WWP1 ameliorates cardiac ischemic injury by suppressing KLF15-ubiquitination mediated myocardial inflammation. In Theranostics, 13, 417-437. doi:10.7150/thno.77694. https://pubmed.ncbi.nlm.nih.gov/36593958/
3. Jiang, Wenna, Liu, Lin, Wang, Meng, Liu, Jing, Ren, Li. 2024. KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. In Cellular and molecular life sciences : CMLS, 81, 417. doi:10.1007/s00018-024-05442-6. https://pubmed.ncbi.nlm.nih.gov/39367978/
4. Li, Xue-Ting, Song, Jia-Wei, Zhang, Zhen-Zhou, Liu, Xiao-Yan, Zhong, Jiu-Chang. 2022. Sirtuin 7 mitigates renal ferroptosis, fibrosis and injury in hypertensive mice by facilitating the KLF15/Nrf2 signaling. In Free radical biology & medicine, 193, 459-473. doi:10.1016/j.freeradbiomed.2022.10.320. https://pubmed.ncbi.nlm.nih.gov/36334846/
5. Zhao, Yuguang, Song, Wenjing, Wang, Lizhe, Han, Fujun, Cai, Lu. 2019. Multiple roles of KLF15 in the heart: Underlying mechanisms and therapeutic implications. In Journal of molecular and cellular cardiology, 129, 193-196. doi:10.1016/j.yjmcc.2019.01.024. https://pubmed.ncbi.nlm.nih.gov/30831134/
6. Hou, Wanqing, Huo, Ku-Geng, Guo, Xiaohua, Ma, Zhenghai, Han, Shuxin. 2024. KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury. In Drug metabolism and disposition: the biological fate of chemicals, 52, 606-613. doi:10.1124/dmd.123.001617. https://pubmed.ncbi.nlm.nih.gov/38670799/
7. Fang, Guangming, Tian, Yexuan, Huang, Shan, Du, Jie, Gao, Shijuan. 2024. KLF15 maintains contractile phenotype of vascular smooth muscle cells and prevents thoracic aortic dissection by interacting with MRTFB. In The Journal of biological chemistry, 300, 107260. doi:10.1016/j.jbc.2024.107260. https://pubmed.ncbi.nlm.nih.gov/38582447/
8. Li, Le, Xu, Weiyi, Zhang, Lilei. 2021. KLF15 Regulates Oxidative Stress Response in Cardiomyocytes through NAD. In Metabolites, 11, . doi:10.3390/metabo11090620. https://pubmed.ncbi.nlm.nih.gov/34564436/
9. Kanyomse, Quist, Le, Xin, Tang, Jun, Zeng, Xiaohua, Xiang, Tingxiu. 2022. KLF15 suppresses tumor growth and metastasis in Triple-Negative Breast Cancer by downregulating CCL2 and CCL7. In Scientific reports, 12, 19026. doi:10.1038/s41598-022-23750-4. https://pubmed.ncbi.nlm.nih.gov/36347994/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
